Literature DB >> 20062638

Pamidronate therapy for hypercalcemia and congenital mesoblastic nephroma: a case report.

Fahimeh Soheilipour1, Mahmood Ashrafi Amineh, Mahin Hashemipour, Ali Asghar Salahi Kojoor, Amir Hosein Davarpanah Jazi.   

Abstract

Hypercalcemia can causes life threatening complications. We report an infant with severe hypercalcemia due to congenital mesoblastic nephroma. Hypercalcemia was corrected before nephrectomy by pamidronate. According to our knowledge this is a rare case with severe neoplasm induced hypercalcemia among neonates who treated by bisphosphonates. The aim of this report is to define new approach to neoplasm induced neonatal hypercalcemia.

Entities:  

Year:  2009        PMID： 20062638      PMCID： PMC2803978          DOI： 10.1186/1757-1626-2-9315

Source DB:  PubMed          Journal:  Cases J        ISSN： 1757-1626


  9 in total

Review 1.  Hypercalcemia in childhood renal tumors.

Authors:  S Jayabose; K Iqbal; L Newman; J A San Filippo; M M Davidian; R Noto; I Sagel
Journal:  Cancer       Date:  1988-02-15       Impact factor: 6.860

2.  Ectopic G-29 and G-37 glucagon secretion by hypercalcemic infantile renal tumors.

Authors:  M F Rousseau-Merck; F Mercier; D Bataille; C Nezelof
Journal:  Peptides       Date:  1986       Impact factor: 3.750

3.  Congenital mesoblastic nephroma associated with polyhydramnios and hypercalcemia.

Authors:  N Daskas; M Argyropoulou; M Pavlou; S Andronikou
Journal:  Pediatr Nephrol       Date:  2002-03       Impact factor: 3.714

4.  Pamidronate: Treatment for severe hypercalcemia in neonatal subcutaneous fat necrosis.

Authors:  Nathalie Alos; Dardye Eugène; Marc Fillion; Julie Powell; Victor Kokta; Gilles Chabot
Journal:  Horm Res       Date:  2006-04-06

5.  Polyhydramnios and hypercalcemia associated with congenital mesoblastic nephroma: case report and a new appraisal.

Authors:  T Y Fung; Y M Fung; P C Ng; C K Yeung; M Z Chang
Journal:  Obstet Gynecol       Date:  1995-05       Impact factor: 7.661

6.  Neonatal hyperparathyroidism and pamidronate therapy in an extremely premature infant.

Authors:  Lisa Fox; Joel Sadowsky; Kevin P Pringle; Alexa Kidd; Jean Murdoch; David E C Cole; Esko Wiltshire
Journal:  Pediatrics       Date:  2007-11       Impact factor: 7.124

Review 7.  Renal tumors in infants less than 6 months of age.

Authors:  Richard D Glick; M John Hicks; Jed G Nuchtern; David E Wesson; Oluyinka O Olutoye; Darrell L Cass
Journal:  J Pediatr Surg       Date:  2004-04       Impact factor: 2.545

8.  Pamidronate treatment for hypercalcemia in an infant receiving parenteral nutrition.

Authors:  Jason J Bryowsky; Mark C Bugnitz; Emily B Hak
Journal:  Pharmacotherapy       Date:  2004-07       Impact factor: 4.705

9.  PTH mRNA transcription analysis in infantile tumors associated with hypercalcemia.

Authors:  M F Rousseau-Merck; Y de Keyzer; A Bourdeau; G Cournot; F Mercier; C Nezelof
Journal:  Cancer       Date:  1988-07-15       Impact factor: 6.860
  9 in total
  3 in total

Review 1.  Review of paraneoplastic syndromes in children.

Authors:  Grace My Ma; Jeanne S Chow; George A Taylor
Journal:  Pediatr Radiol       Date:  2019-03-16

2.  Use of Calcitonin for Hypercalcemia in a Premature Neonate With Congenital Mesoblastic Nephroma.

Authors:  Malia S Kleespies; Pooja A Shah; Deborah S Bondi
Journal:  J Pediatr Pharmacol Ther       Date:  2022-09-26

3.  Neonatal congenital mesoblastic nephroma that caused respiratory oncologic emergency early after birth: a case report.

Authors:  Hirotaka Kato; Yasuyuki Mitani; Taro Goda; Hiroki Yamaue
Journal:  BMC Pediatr       Date:  2022-03-17       Impact factor: 2.125
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.